Results 121 to 130 of about 4,267 (203)

The relationship of soluble urokinase plasminogen activator receptor levels with preterm premature rupture of membranes and predictive value in neonatal intensive care unit admission. [PDF]

Rev Assoc Med Bras (1992)
Koc BL, Tanacan A, Haliloglu E, Yilmaz HE, Ersak DT, Aktas BA, Kara O, Sahin D.   +7 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR): Role in the Risk Stratification of Potentially Infected Patients Presenting at the Emergency Department. [PDF]

Diagnostics (Basel)
Baldetti M, Velocci S, Belardi R, Di Lecce VN, Paganelli C, Fortunato NA, Ricciardulli T, Terrinoni A, Pieri M, Bernardini S, Legramante JM, Minieri M.   +11 more
europepmc   +1 more source

Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction. [PDF]

Neuromolecular Med
de Rezende VL, Mathias K, Danielski LG, Barichello T, Petronilho F.   +4 more
europepmc   +1 more source

Establish suPAR measurements

Set-up of suPAR measurements in 14 Intensive Care Units (ICUs) in Greece. Three of these already have suPAR set-up, but 11 need to have the suPARnostic QT or suPARnostic Turbidimetric assay ...
openaire   +1 more source

From heart to kidney: FGF23, SuPAR, and NAG as early biomarkers of cardiorenal syndrome in acute heart failure. [PDF]

BMC Cardiovasc Disord
El-Desouki IM, Salah NA, Aziz HMMA, El-Khawaga OY.   +3 more
europepmc   +1 more source

The significance of soluble urokinase plasminogen activator receptor (suPAR) in ICU Patients

, 2013
ÖZET İnflamasyon ve koagülasyona eğilim, çeşitli kritik hastalık durumlarında anahtar patojenik faktörlerdir. Soluble urokinase plasminogen activator (suPAR) immünolojik olarak aktif hücrelerden salınan, fibrinoliz ve inflamasyonu yansıtan bir

core  

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease. [PDF]

Diabetes Care
Sakr SM, Desai S, Medina-Inojosa J, Liu C, Razavi AC, Yadalam AK, Ko YA, Ahmed T, Harris KA, Huang J, Yeboah R, Haroun N, Hartsfield JD, Owais M, Lodhi R, Eldaidamouni AA, Al Kasem M, Ali MK, Narayan KMV, Pasquel FJ, Tandon N, Mohan V, Quyyumi AA.   +22 more
europepmc   +1 more source

Insight to Neglected Biomarkers in COVID-19: A Comprehensive Narrative Review". [PDF]

Biomark Insights
Jalilian S, Bastani MN, Afsharzadeh F.
europepmc   +1 more source

A Narrative Review on Abnormalities in the Hemostatic System in Diabetes Mellitus: Pathophysiology, Clinical Implications, and Therapeutics. [PDF]

Life (Basel)
Rafaqat S, Hamid H, Bashir F, Abaid H, Klisic A, Rafaqat S, Mercantepe F.   +6 more
europepmc   +1 more source

Methodological and Clinical Gaps in Biomarker-Guided Weaning for Sepsis-Induced ARDS [Letter]. [PDF]

J Inflamm Res
Lu CW, Chang KC.
europepmc   +1 more source